Actively Recruiting
Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii
Led by Queen's Medical Center · Updated on 2026-03-31
40
Participants Needed
1
Research Sites
115 weeks
Total Duration
On this page
Sponsors
Q
Queen's Medical Center
Lead Sponsor
N
National Institute of General Medical Sciences (NIGMS)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to use contingency management (CM) as an intervention tool to address methamphetamine use. The main objectives are to: * Gather effectiveness data on a pilot a CM program for participants in Hawaii who use methamphetamine following hospitalization due to traumatic injury * To assess participant perspectives on engaging with a CM program based at a Level 1 Trauma Center. Researches will assess both patient-reported and biologically-confirmed medium-term program effectiveness and conduct qualitative interviews with participants post-program. Participants will: * Visit a follow-up clinic up to three times per week to complete urinalysis following discharge from the trauma unit * Complete Treatment Effectiveness Assessments at 6 and 12-weeks * Engage in a qualitative interview at the end of the CM program
CONDITIONS
Official Title
Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admitted trauma patients
- Age greater than 18 years old
- Urine drug screen positive for methamphetamines during the current hospitalization
- Report at least weekly methamphetamine use
- First methamphetamine use greater than 6 months prior to injury
- Report at least 4 DSM-V Amphetamine-Type Substance Use Disorder symptoms (at least moderate disease)
- Glasgow Coma Scale 13 upon arrival to the emergency department
- Ability to understand and participate in study procedures
- Ability to communicate in English
You will not qualify if you...
- Active psychosis (reporting auditory or visual hallucinations)
- Under ongoing cardiorespiratory monitoring
- Evidence of moderate or severe traumatic brain injury
- Patients who are known to be pregnant
- Prisoner
- Individuals incarcerated at the time of their hospitalization
- Individuals lacking capacity to provide, or are otherwise unable or unwilling to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Queen's Medical Center
Honolulu, Hawaii, United States, 90813
Actively Recruiting
Research Team
N
Nicholas R Schumann, Clinical Psychologist
CONTACT
K
Karen Ng, RN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here